**Beech Tree Labs, Inc.** is a biopharmaceutical company with the mission to address unmet medical needs affecting millions of people. Founded in **2005** and based in the **United States**, Beech Tree Labs focuses on developing formulations that target the body’s signals to restore a healthy equilibrium. Their slogan, "We address unmet medical needs affecting the life of millions of people by restoring the body’s healthy equilibrium," reflects their commitment to medical innovation. The company has recently attracted significant investment, with a notable **Series B investment** of **$7.00M** secured on **09 December 2010**. Despite not specifying the investors for this particular round, this injection of capital demonstrates confidence in Beech Tree Labs' potential to make a positive impact in the biopharma, biotechnology, and pharmaceutical sectors. With a clear focus on developing solutions for unmet medical needs, Beech Tree Labs appears poised to leverage this investment to further their research and development initiatives, potentially unlocking groundbreaking therapies that could improve the lives of millions. This recent investment underscores the continued interest and support for innovative companies addressing critical healthcare challenges. In summary, Beech Tree Labs, Inc. stands at the forefront of addressing unmet medical needs, and the recent **Series B investment** serves as a testament to the potential impact of their ongoing efforts in the biopharmaceutical space.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series B | $7.00M | - | 09 Dec 2010 | |
Venture Round | $1.46M | - | 15 Mar 2010 |
No recent news or press coverage available for Beech Tree Labs, Inc..